MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Tremor and parkinsonism in Chromosomopathies – a systematic review

    V. Carvalho, L. Guedes (Matosinhos, Portugal)

    Objective: To review the co-occurrence of parkinsonism and tremor syndromes in patients with chromosomic disorders. Background: The landscape of genetic forms of Parkinson’s diseases (PD)…
  • 2019 International Congress

    The potential modifier effect of C9orf72 DNA methylation in C9ORF72 carriers

    JM. Laffita-Mesa, CH. Kreidy, M. Paucar, P. Svenningsson (Stockholm, Sweden)

    Objective: To develop molecular assays for determining the influence of hypermethylation on age of onset for C9ORF72 carriers. Background: Hexanucleotide repeats of GGGGCC in C9ORF72 is…
  • 2019 International Congress

    Serum MIR-96-5P and MIR-339-5P as a Potential Biomarker for Multiple System Atrophy and Parkinson’s Disease

    A. Vallelunga, T. Iannitti, S. Capece, G. Somma, G. Dati, P. Barone, W. Meissner, M. Pellecchia (Salerno, Italy)

    Objective: The aim of our study was to to determine if serum mir-96-5p and mir-339-5p can be used as biomarkers for early diagnosis of Parkinson’s…
  • 2019 International Congress

    Hypophosphatasia presenting as parkinsonism with compound heterozygous mutations in ALPL gene

    WF. Yu, ZX. Zhao, LW. Liu, JL. Hu, FF. Wang, YM. Liu (Jinan, China)

    Objective: We report a hypophosphatasia patient presenting as parkinsonism, characterized by compound heterozygous mutations in ALPL gene. Background: Hypophosphatasia (HPP) is a rare metabolism disease,…
  • 2019 International Congress

    Correlation Between Drooling and Quality of Life in Parkinson’s Disease

    O. Criciotoiu, D. Stanca, R. Latea, L. Giurgiulescu, A. Mita, V. Gheorman, D. Gheonea (Craiova, Romania)

    Objective: The aim of this study was to evaluate the relationship between the quality of life and drooling in Parkinson’s disease patients. Background: Parkinson’s disease…
  • 2019 International Congress

    Association between Gait during Daily Life and Clinical Measures: Effects of Bout Length

    V. Shah, J. Mcnames, C. Curtze, M. Mancini, P. Carlson-Kuhta, J. Nutt, M. El Gohary, F. Horak (Portland, OR, USA)

    Objective: In this study, we investigated how the association between gait during daily life and clinical measures changes with walking bouts of different lengths in…
  • 2019 International Congress

    Pulmonary function in patients with Parkinson’s disease

    V. Israel, B. Yamaguchi, M. Ferreira, S. Valderramas (Curitiba, Brazil)

    Objective: Analyse the pulmonary function in patients with PD. Background: Respiratory disorders are the most common causes of death in people with Parkinson's disease (PD)(1,2).…
  • 2019 International Congress

    Movement Disorders in Post Stroke Patients: A Retrospective Analysis

    M. Christie, V. Laticevschi, R. Mehanna (Houston, TX, USA)

    Objective: To review the prevalence of various movement disorders in post stroke patients at a tertiary, academic center and to characterize the therapeutic response to…
  • 2019 International Congress

    Language characteristics of picture description task by Hebrew speaking patients with Parkinson’s disease

    D. Shpunt, S. Naor, N. Diamant, A. Faust-Socher, H. Shabtai, R. Peled, A. Migirov, T. Gurevich, Y. Manor (Tel Aviv, Israel)

    Objective: To characterize picture description by patients with PD Hebrew speakers. Background: Non-motor symptoms in Parkinson’s disease (PD) such as cognitive decline, depression and language…
  • 2019 International Congress

    The trace of substantia nigra hyperechogenicity: a clinical observation

    A. Alonso-Canovas, JL. Sendon-Moreno, G. Garcia-Ribas, N. Monterde-Gonzalez, C. Jara-Laguna, JC. Martinez-Castrillo, J. Masjuan (Madrid, Spain)

    Objective: To present an empirical observation regarding transcranial ultrasound in movement disorders and scalp sebum smear. Background: Transcranial ultrasound (TUS) detects substantia nigra hyperechogenicity (SN+) in…
  • « Previous Page
  • 1
  • …
  • 182
  • 183
  • 184
  • 185
  • 186
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley